<?xml version="1.0" encoding="UTF-8"?>
<p id="Par42">SARS-CoV entry into cells has been shown to downregulate ACE2 expression
 <sup>
  <xref ref-type="bibr" rid="CR62">62</xref>,
  <xref ref-type="bibr" rid="CR106">106</xref>,
  <xref ref-type="bibr" rid="CR107">107</xref>
 </sup>. In a mouse model of SARS, ACE2 levels in the heart were significantly reduced after SARS-CoV infection
 <sup>
  <xref ref-type="bibr" rid="CR62">62</xref>
 </sup>. In addition, a separate study reported that knockout of 
 <italic>Ace2</italic> in mice resulted in a significant reduction in cardiac contractility
 <sup>
  <xref ref-type="bibr" rid="CR108">108</xref>
 </sup>. Furthermore, 
 <italic>Ace2</italic>
 <sup>
  <italic>–/–</italic>
 </sup>
 <italic>Apoe</italic>
 <sup>
  <italic>–/–</italic>
 </sup> mice had greater atherosclerotic plaque accumulation and upregulated expression of genes encoding adhesion molecules and inflammatory cytokines such as IL-6 and CCL2 compared with 
 <italic>Apoe</italic>
 <sup>
  <italic>–/–</italic>
 </sup> mice
 <sup>
  <xref ref-type="bibr" rid="CR109">109</xref>
 </sup>. These results support a cardioprotective role of ACE2 (ref.
 <sup>
  <xref ref-type="bibr" rid="CR61">61</xref>
 </sup>).
</p>
